Vascular Solutions (VASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 147,200 | 126,099 | 110,498 | 98,386 | 89,956 |
| Cost of Goods | 48,903 | 41,699 | 36,156 | 32,561 | 29,844 |
| Gross Profit | 98,297 | 84,400 | 74,342 | 65,825 | 60,112 |
| Operating Expenses | 85,601 | 65,172 | 58,401 | 50,481 | 45,370 |
| Operating Income | 13,599 | 19,927 | 16,097 | 15,905 | 15,586 |
| Interest Expense | 0 | 0 | 0 | 0 | 13 |
| Other Income | 42 | -15 | -14 | -13 | 126 |
| Pre-tax Income | 13,641 | 19,912 | 16,083 | 15,892 | 15,699 |
| Income Tax | 3,177 | 7,178 | 4,941 | 5,983 | 5,960 |
| Net Income Continuous | 10,464 | 12,734 | 11,142 | 9,909 | 9,739 |
| Net Income | $10,464 | $12,734 | $11,142 | $9,909 | $9,739 |
| EPS Basic Total Ops | 0.61 | 0.75 | 0.68 | 0.62 | 0.59 |
| EPS Basic Continuous Ops | 0.61 | 0.75 | 0.68 | 0.62 | 0.59 |
| EPS Diluted Total Ops | 0.58 | 0.72 | 0.65 | 0.60 | 0.57 |
| EPS Diluted Continuous Ops | 0.58 | 0.72 | 0.65 | 0.60 | 0.57 |
| EPS Diluted Before Non-Recurring Items | 1.11 | 0.72 | 0.73 | 0.60 | 0.46 |
| EBITDA(a) | $19,595 | $24,826 | $20,530 | $19,456 | $18,532 |